MedPath

Exercise therapy intervention for children and young adults with cerebral palsy

Not Applicable
Completed
Conditions
Nervous System Diseases
Cerebral Palsy
Cerebral palsy
Registration Number
ISRCTN69044459
Lead Sponsor
niversity of Jyväskylä
Brief Summary

2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/33637124/ protocol (added 01/03/2021) 2022 Interim results article in https://doi.org/10.3389%2Ffbioe.2022.897852 (added 12/12/2022) 2023 Results article in https://doi.org/10.1249/MSS.0000000000003273 (added 18/09/2023) 2022 Results article in https://doi.org/10.3389/fbioe.2022.897852 (added 18/09/2023)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
36
Inclusion Criteria

Current participant inclusion criteria as of 20/06/2019:
Experimental group:
1. Spastic CP (diplegic or hemiplegic)
2. Male and Female
3. Age range of 9 to 24 years old
4. Gross Motor Function Classification System (Palisano et al. 2008) levels 1 to 3

Control group:
1. Typically developing
2. Male and Female
3. Age range of 9 to 24 years old

Previous participant inclusion criteria:
Experimental group:
1. Spastic CP (diplegic or hemiplegic)
2. Male and Female
3. Age range of 10 to 23 years old
4. Gross Motor Function Classification System (Palisano et al. 2008) levels 1 to 3

Control group:
1. Typically developing
2. Male and Female
3. Age range of 10 to 23 years old

Exclusion Criteria

1. Pharmacological treatments (e.g. intrathecal baclofen, botullinum toxin) in the last 6 months
2. Surgical procedures in the last 6 months
3. Selective dorsal rhyzotomy
4. Dystonia
5. Inability to understand basic instructions
6. Current utilization of serial casting
7. Inability to stand with the sole of the foot flat on the floor
8. Participation in the past 3 months in a structured physical training program

*Exclusion criteria 1 to 3 may be accepted as a case study (added 20/06/2019).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<br> Current primary outcome measure as of 20/06/2019:<br> Gait performance is assessed using a six minute walking test. Gait kinetics/kinematics/mechanical efficiency is assessed using Vicon cameras, force plates and a heart rate monitor at pre-tests 1 and 2, and post-tests 1 and 2 for the CP group and pre-tests 1 and 2 for the control group.<br><br> Previous primary outcome measure:<br> Gait performance is assessed using a 6 minutes walking test at baseline (pre-test 1), 3 (pre-test 2), 6 (post-test 1) and 9 (post-test 2) months for participants with CP and at baseline and 3 months for control participants.<br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath